Radiation Oncology Device Approval in the United States and Canada.
PMID : 31192056 ·
C, r, a, i, g, , A, , B, e, e, r, s, ;, , W, e, n, d, y, , L, , S, m, i, t, h, ;, , S, a, r, a, h, , W, e, p, p, l, e, r, ;, , C, o, l, l, e, e, n, , S, c, h, i, n, k, e, l, ;, , H, a, r, v, e, y, , Q, u, o, n
Publicité
Résumé
Background Medical devices are a crucial component in the field of radiation oncology. The review and licensing of radiation oncology devices (RODs) is managed on a national basis in Canada by Health Canada and in the United States by the Food and Drug Administration (FDA). The purpose of this study was to examine differences in ROD licensing timelines between Health Canada and the FDA that may impact the ability of Canadians to access the most up-to-date radiation oncology care. Methods A list
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.